Brief: Corcept Therapeutics Q1 EPS USD -0.3
30/04/2026 21:05
Apr 30 (Reuters) - Corcept Therapeutics Q1 revenue USD 164.903 million vs. IBES estimate USD 192.5 million. Q1 net income USD -31.761 million
Recent news on Corcept Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Salesforce, Snowflake, Zscaler
Brief: Corcept To Resubmit NDA For Relacorilant As Treatment For Cushing's Syndrome Patients
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International
Corcept Q1 revenue rises but misses analyst estimates
Brief: Corcept Therapeutics Q1 EPS USD -0.3